NCT05533697pembrolizumabmRNA-4359Moderna, Inc.CPI-R/R melanomamelanoma
…with mRNA-4359 plus pembrolizumab.Methods In an ongoing trial ( NCT05533697), as of 28Feb2025, 29 patients with CPI-R/R melanoma received p…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT05533697 ×
NCT05533697
This institution is selected. Its supporting articles are shown below.